Halt Medical Starts Venture Capital Debt Funding


	Subscribe \| Contact Us \|

Friday, February 03, 2012 5:56:00 AM PDT | VentureDeal Staff

Brentwood, California -- Medical device company Halt Medical has secured $20 million in venture capital debt financing, according to an SEC regulatory filing.

Halt says that it is developing a urine fibroid treatment device, designed specifically to ablate uterine fibroids.

Investors in the financing were not disclosed, nor was how the company intends to use the proceeds.

Halt is still seeking $11.3 million in additional financing, according to the filing.

Email Page | Print Page

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.